{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:40:24Z","timestamp":1788273624511,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.drugalcdep.2019.107700","type":"journal-article","created":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T07:23:15Z","timestamp":1572679395000},"page":"107700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Extended release mixed amphetamine salts and topiramate for cocaine dependence: A randomized clinical replication trial with frequent users"],"prefix":"10.1016","volume":"206","author":[{"given":"Frances R.","family":"Levin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Pavlicova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Jean","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Mahony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Bisaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Dakwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth M.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasir","family":"Naqvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward V.","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Kampman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.drugalcdep.2019.107700_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2012.12.013","article-title":"Antipsychotic drugs in cocaine dependence: a systematic review and meta-analysis","volume":"45","author":"Alvarez","year":"2013","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.107700_bib0010","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000"},{"issue":"17","key":"10.1016\/j.drugalcdep.2019.107700_bib0015","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial","volume":"295","author":"Anton","year":"2006","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.drugalcdep.2019.107700_bib0020","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1080\/14656566.2016.1244529","article-title":"Update on pharmacotherapy for treatment of opioid use disorder","volume":"17","author":"Ayanga","year":"2016","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.drugalcdep.2019.107700_bib0025","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006103.pub5","article-title":"Nicotine receptor partial agonists for smoking cessation","volume":"2","author":"Cahill","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2019.107700_bib0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.drugalcdep.2014.01.012","article-title":"Toward empirical identification of a clinically meaningful indicator of treatment outcome: features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine use outcomes","volume":"137","author":"Carroll","year":"2014","journal-title":"Drug Alcohol Depend."},{"issue":"7","key":"10.1016\/j.drugalcdep.2019.107700_bib0035","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1177\/1087054712468486","article-title":"Nonmedical use and diversion of ADHD stimulants among U.S. adults ages 18-49: a national internet survey","volume":"19","author":"Cassidy","year":"2015","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.drugalcdep.2019.107700_bib0040","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007380.pub3","article-title":"Efficacy of psychostimulant drugs for cocaine dependence","volume":"2","author":"Castells","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.drugalcdep.2019.107700_bib0045","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1124\/pr.115.011668","article-title":"Evaluation of the \u201cPipeline\u201d for development of medications for cocaine use disorder: A review of translational preclinical, human laboratory and clinical trial research","volume":"68","author":"Czoty","year":"2016","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.drugalcdep.2019.107700_bib0050","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jsat.2011.12.014","article-title":"A double-blind, placebo-controlled trial of modafinil for cocaine dependence","volume":"43","author":"Dackis","year":"2012","journal-title":"J. Subst. Abuse Treat."},{"issue":"4","key":"10.1016\/j.drugalcdep.2019.107700_bib0055","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/(SICI)1098-2396(199704)25:4<393::AID-SYN11>3.0.CO;2-W","article-title":"GABAergic attenuation of cocaine-induced dopamine release and locomotor activity","volume":"25","author":"Dewey","year":"1997","journal-title":"Synapse"},{"key":"10.1016\/j.drugalcdep.2019.107700_bib0060","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.drugalcdep.2016.02.045","article-title":"Feasibility and success of cell-phone assisted remote observation of medication adherence (CAROMA) in clinical trials","volume":"163","author":"DeWorsop","year":"2016","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.drugalcdep.2019.107700_bib0065","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1176\/appi.ajp.2007.06111851","article-title":"A meta-analytic review of psychosocial interventions for substance use disorders","volume":"165","author":"Dutra","year":"2008","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.drugalcdep.2019.107700_bib0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/ijerph8010015","article-title":"Blocked randomization with randomly selected block sizes","volume":"8","author":"Efrid","year":"2011","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.drugalcdep.2019.107700_bib0075","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neubiorev.2018.02.001","article-title":"The pharmacology of amphetamine and methylphenidate: relevance to the neurobiology of attention-deficit\/hyperactivity disorder and other psychiatric comorbidities","volume":"87","author":"Faraone","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.drugalcdep.2019.107700_bib0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","article-title":"Bias reduction of maximum likelihood estimates","volume":"80","author":"Firth","year":"1993","journal-title":"Biometrika"},{"key":"10.1016\/j.drugalcdep.2019.107700_bib0085","series-title":"Statistical Methods for Rates and Proportions","author":"Fleiss","year":"2013"},{"issue":"Suppl 1","key":"10.1016\/j.drugalcdep.2019.107700_bib0090","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/j.1528-1157.2000.tb02164.x","article-title":"Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons","volume":"41","author":"Gibbs","year":"2000","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.drugalcdep.2019.107700_bib0095","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00004714-200110000-00010","article-title":"Dextroamphetamine for cocaine-dependence treatment: a double blind randomized clinical trial","volume":"21","author":"Grabowski","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.drugalcdep.2019.107700_bib0100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1469-1809.1955.tb01285.x","article-title":"The estimation and significance Of The logarithm Of A ratio Of frequencies","volume":"20","author":"Haldane","year":"1956","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.drugalcdep.2019.107700_bib0105","first-page":"76","article-title":"Agonist-like pharmacotherapy for stimulant dependence: preclinical human laboratory, and clinical studies","volume":"2","author":"Herin","year":"2010","journal-title":"Addict. Rev."},{"issue":"1-2","key":"10.1016\/j.drugalcdep.2019.107700_bib0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.drugalcdep.2012.08.007","article-title":"Assessment of riboflavin as a tracer substance: comparison of a qualitative to a quantitative method of riboflavin measurement","volume":"128","author":"Herron","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"7","key":"10.1016\/j.drugalcdep.2019.107700_bib0115","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.addbeh.2004.06.014","article-title":"Topiramate-induced neuromodulation of cortico-mesolimbic dopamine function: a new vista for the treatment of comorbid alcohol and nicotine dependence?","volume":"29","author":"Johnson","year":"2004","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2019.107700_bib0120","series-title":"Handbook of Clinical Alcoholism Treatment","first-page":"282","article-title":"Brief behavioral compliance enhancement treatment (BBCET) manual","author":"Johnson","year":"2003"},{"issue":"2","key":"10.1016\/j.drugalcdep.2019.107700_bib0125","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/01.ALC.0000153542.10188.B0","article-title":"Safety and efficacy of GABAergic medications for treating alcoholism","volume":"29","author":"Johnson","year":"2005","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2019.107700_bib0130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.15288\/jsas.2005.s15.157","article-title":"The COMBINE SAFTEE: a structured instrument for collecting adverse events adapted for clinical studies in the alcoholism field","volume":"15","author":"Johnson","year":"2005","journal-title":"J. Stud. Alcohol. Suppl."},{"issue":"12","key":"10.1016\/j.drugalcdep.2019.107700_bib0135","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jamapsychiatry.2013.2295","article-title":"Topiramate for the treatment of cocaine addiction: a randomized clinical trial","volume":"70","author":"Johnson","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.drugalcdep.2019.107700_bib0140","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.drugalcdep.2004.03.008","article-title":"A pilot trial of topiramate for the treatment of cocaine dependence","volume":"75","author":"Kampman","year":"2004","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.drugalcdep.2019.107700_bib0145","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.drugalcdep.2013.05.026","article-title":"A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence","volume":"133","author":"Kampman","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.drugalcdep.2019.107700_bib0150","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/add.13618","article-title":"How can we investigate the role of topiramate in the treatment of cocaine use disorder more thoroughly?","volume":"112","author":"Klimas","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.107700_bib0155","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003023.pub2","article-title":"Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders","volume":"3","author":"Knapp","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.drugalcdep.2019.107700_bib0160","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/1087054707311654","article-title":"ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines","volume":"12","author":"Kollins","year":"2008","journal-title":"J. Atten. Disord."},{"issue":"3","key":"10.1016\/j.drugalcdep.2019.107700_bib0165","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0376-8716(03)00032-2","article-title":"Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients","volume":"70","author":"Kosten","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107700_bib0170","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1081\/SAC-200040691","article-title":"Small sample confidence intervals for the odds ratio","volume":"33","author":"Lawson","year":"2004","journal-title":"Commun. Stat. Simul. Comput."},{"issue":"6","key":"10.1016\/j.drugalcdep.2019.107700_bib0175","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/jamapsychiatry.2015.41","article-title":"Extended-release mixed amphetamine salts vs placebo for comorbid adult attention-deficit\/hyperactivity disorder and cocaine use disorder: a randomized clinical trial","volume":"72","author":"Levin","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"10.1016\/j.drugalcdep.2019.107700_bib0180","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/add.12608","article-title":"Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder","volume":"109","author":"Ling","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.107700_bib0185","series-title":"Measuring Alcohol Consumption: Psychosocial and Biochemical Methods","author":"Litten","year":"1992"},{"issue":"11","key":"10.1016\/j.drugalcdep.2019.107700_bib0190","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.biopsych.2012.05.032","article-title":"Extended-release mixed amphetamine salts and topiramate for cocaine dependence: a randomized controlled trial","volume":"72","author":"Mariani","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.107700_bib0195","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006754.pub3","article-title":"Anticonvulsants for cocaine dependence","volume":"4","author":"Minozzi","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2019.107700_bib0200","article-title":"Dopamine agonists for the treatment of cocaine dependence","volume":"5","author":"Minozzi","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.drugalcdep.2019.107700_bib0205","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/00952990701313686","article-title":"Citalopram combined with behavioral therapy reduces cocaine use: a double-blind, placebo-controlled trial","volume":"33","author":"Moeller","year":"2007","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"8","key":"10.1016\/j.drugalcdep.2019.107700_bib0210","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1038\/npp.2014.322","article-title":"Agonist medications for the treatment of cocaine use disorder","volume":"40","author":"Negus","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2019.107700_bib0215","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.drugalcdep.2014.02.024","article-title":"Treatment of crack-cocaine dependence with topiramate: A randomized controlled feasibility trial in The Netherlands","volume":"138","author":"Nuitjen","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107700_bib0220","article-title":"Antidepressants for cocaine dependence and problematic cocaine use","volume":"12","author":"Pani","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.drugalcdep.2019.107700_bib0225","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archpsyc.63.2.219","article-title":"Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population","volume":"63","author":"Poling","year":"2006","journal-title":"Arch Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.107700_bib0230","series-title":"Columbia-Suicide Severity Rating Scale (C-SSRS)","author":"Posner","year":"2008"},{"issue":"2","key":"10.1016\/j.drugalcdep.2019.107700_bib0235","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4155\/fmc.11.184","article-title":"Agonist replacement therapy for cocaine dependence: a translational review","volume":"4","author":"Rush","year":"2012","journal-title":"Future Med. Chem."},{"issue":"1-3","key":"10.1016\/j.drugalcdep.2019.107700_bib0240","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.drugalcdep.2008.08.009","article-title":"Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy","volume":"99","author":"Rush","year":"2009","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.drugalcdep.2019.107700_bib0245","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/JCP.0b013e3181d21967","article-title":"Cocaine choice in humans during D-amphetamine maintenance","volume":"30","author":"Rush","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.drugalcdep.2019.107700_bib0250","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/syn.10000","article-title":"Topiramate selectively attenuates nicotine-induced increases in monoamine release","volume":"42","author":"Schiffer","year":"2001","journal-title":"Synapse"},{"issue":"1-3","key":"10.1016\/j.drugalcdep.2019.107700_bib0255","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.drugalcdep.2007.11.004","article-title":"Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform","volume":"94","author":"Schmitz","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107700_bib0260","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fpsyt.2012.00077","article-title":"Combination of modafinil and d-amphetamine for the treatment of cocaine dependence: a preliminary investigation","volume":"3","author":"Schmitz","year":"2012","journal-title":"Front. Psychiatry"},{"issue":"Suppl 20","key":"10.1016\/j.drugalcdep.2019.107700_bib0265","first-page":"22","article-title":"The mini-International neuropsychiatric interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"issue":"8","key":"10.1016\/j.drugalcdep.2019.107700_bib0270","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/add.13328","article-title":"Topiramate for cocaine dependence: a systematic review and meta-analysis of randomized controlled trials","volume":"111","author":"Singh","year":"2016","journal-title":"Addiction"},{"issue":"Suppl 1","key":"10.1016\/j.drugalcdep.2019.107700_bib0275","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1111\/j.1528-1157.2000.tb02171.x","article-title":"Topiramate blocks kainate-evoked cobalt influx into cultured neurons","volume":"41","author":"Skradski","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.drugalcdep.2019.107700_bib0280","first-page":"304","article-title":"The brief substance craving scale \u2013 measuring craving in clinical trials","volume":"180","author":"Somoza","year":"1999","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.drugalcdep.2019.107700_bib0285","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2017 National Survey on Drug Use and Health","author":"Substance Abuse and Mental Health Services Administration","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.107700_bib0290","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.drugalcdep.2014.03.033","article-title":"Topiramate for cocaine dependence during methadone maintenance treatment: a randomized controlled trial","volume":"140","author":"Umbricht","year":"2014","journal-title":"Drug. Alcohol. Depend."},{"issue":"2-3","key":"10.1016\/j.drugalcdep.2019.107700_bib0295","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drugalcdep.2007.05.028","article-title":"A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence","volume":"91","author":"Winhusen","year":"2007","journal-title":"Drug. Alcohol. Depend."},{"issue":"5","key":"10.1016\/j.drugalcdep.2019.107700_bib0300","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/cap.2011.0014","article-title":"Subjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention-deficit\/hyperactivity disorder","volume":"21","author":"Winhusen","year":"2011","journal-title":"J. Child Adolesc. Psychopharmacol."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619304776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619304776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:04:51Z","timestamp":1759827891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871619304776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":60,"alternative-id":["S0376871619304776"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107700","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extended release mixed amphetamine salts and topiramate for cocaine dependence: A randomized clinical replication trial with frequent users","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107700","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107700"}}